Company
United StatesPublic company, NASDAQ: AYTUAytu Biopharma, Inc. (NASDAQ: AYTU), Denver, CO – FDA Inspections
Inspection records and compliance data for Aytu Biopharma, Inc. in Denver, CO. 1 FDA inspection on record, 1 Form 483, last inspected September 25, 2026. Publicly traded as NASDAQ: AYTU.
Company Profile
This profile covers Aytu Biopharma, Inc. based in Denver, CO, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected September 25, 2026.
Most cited issue areas
- Failure to develop written procedures1 inspection
- Failure to maintain records1 inspection
- Inconsistent unique case identification number ICSR1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 25, 2026 | Not classified | Human Drugs · Postmarket Surv. and Epidemiology | 1338580 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Aytu Biopharma, Inc.
Stock ticker
AYTU
Exchange
NASDAQ
Share price
$1.79
Market cap
$19.5M
Price as of
November 13, 2026
FEI Number
3042587830
Address
7900 E Union Ave Ste 920, Denver, CO 80237-2776, United States
Country
United States
ID: cd6e1d45-9676-4e20-9c4b-2f2a04f363ec